IQVIA Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 01:30PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. I'm Luke Sergott, the life science tools diagnostics analyst here at Barclays. Today, I have Ron Bruehlman from IQVIA, CFO. And I think we can just probably get right into it, if it's good with you.

Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO

Okay. Great.

Questions and Answers:

Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

So off the top here, let's go taking off the macro headwinds. Let's tick off the top today. SVB exposure and just walk us through that.

Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO

I figured that would probably be the first question. A week ago, I would have had no idea. But look, overall, what I would say is it's not a big concern for us at least so far as what we can see right now. And as far as our own relationship with SVB, we have no loans whatsoever with them. We
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot